Journal for ImmunoTherapy of Cancer (Nov 2021)

617 Trastuzumab and pertuzumab combination therapy activates complement-dependent cytotoxicity and phagocytosis against HER2+ breast cancer

Zachary Hartman,
Li-Chung Tsao

Affiliations

Zachary Hartman: Aff2 grid.26009.3d0000000419367961Duke University Durham NC USA
Li-Chung Tsao: Duke University, Durham, NC, USA

DOI: https://doi.org/10.1136/jitc-2021-SITC2021.617
Journal volume & issue: Vol. 9, no. Suppl 2

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal